Medicine and Dentistry
Gut
100%
Neutrophil
45%
Peptide
45%
Analysis
27%
Blood
27%
Dextran Sulfate
18%
Ex Vivo
18%
Colitis
18%
Ulcerative Colitis
18%
Crohn's Disease
18%
Patient
9%
C Reactive Protein
9%
Therapeutic Procedure
9%
Leukocyte
9%
Serositis
9%
Intestine Biopsy
9%
Enzyme Linked Immunosorbent Assay
9%
In Silico
9%
Sense
9%
Biological Marker
9%
Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase
9%
Tissues
9%
Calgranulin
9%
Infliximab
9%
Marker
9%
Reactive Oxygen Species
9%
Patient with Inflammatory Bowel Disease
9%
Vedolizumab
9%
Disease Activity
9%
Ustekinumab
9%
Biochemistry, Genetics and Molecular Biology
Peptide Receptor
100%
Peptide
45%
Cyclosporins
18%
Dextran
18%
Dehydrogenase
9%
Infliximab
9%
C-Reactive Protein
9%
Nicotinamide Adenine Dinucleotide
9%
Ustekinumab
9%
Immunology and Microbiology
Inflammation
100%
Neutrophil Granulocyte
41%
Crohn's Disease
16%
Ulcerative Colitis
16%
Colitis
16%
Innate Immune System
8%